British American Tobacco

Strong New Categories led by Modern Oral

02/06/26 -"New categories showed accelerated revenue growth, with BAT raising FY2026 revenue growth expectations to mid-teens, driven by Modern Oral and, to a lesser extent, Vapour. Velo is the key growth ..."

PDF page sample
Pages
53
Language
English
Published on
02/06/26
Download
You may also be interested by these reports :
02/06/26
New categories showed accelerated revenue growth, with BAT raising FY2026 revenue growth expectations to mid-teens, driven by Modern Oral and, to a ...
02/06/26
Six months into his tenure, CEO Schumacher has introduced the new strategic plan, ‘Focus for Growth’. This plan signifies a reset following a ...
26/05/26
We have updated our model to incorporate the FY25/26 reported figures. The significant impact on the FY25/26 EPS is from the integration of ...
21/05/26
Südzucker released its FY25/26 annual report, confirming preliminary figures without surprises. The year was marked by significant losses in the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO